X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (63514) 63514
Newspaper Article (8671) 8671
Newsletter (4916) 4916
Book Chapter (472) 472
Magazine Article (442) 442
Trade Publication Article (145) 145
Transcript (94) 94
Book / eBook (59) 59
Dissertation (52) 52
Web Resource (47) 47
Government Document (15) 15
Report (12) 12
Book Review (10) 10
Reference (7) 7
Conference Proceeding (4) 4
Streaming Video (3) 3
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46686) 46686
hepatitis (27042) 27042
male (26140) 26140
female (24867) 24867
middle aged (20433) 20433
adult (19983) 19983
hepatitis c (18331) 18331
gastroenterology & hepatology (17119) 17119
hepatitis c virus (15503) 15503
antiviral agents - therapeutic use (15466) 15466
interferon (12746) 12746
hepatitis c, chronic - drug therapy (12078) 12078
health aspects (11432) 11432
liver (9722) 9722
aged (9630) 9630
treatment outcome (9589) 9589
hepatitis b (9214) 9214
infection (9095) 9095
infections (9021) 9021
infectious diseases (8193) 8193
care and treatment (7777) 7777
drug therapy (7650) 7650
liver diseases (7622) 7622
research (7616) 7616
therapy (7540) 7540
risk factors (7247) 7247
drug therapy, combination (7205) 7205
interferon-alpha - therapeutic use (7182) 7182
virology (6646) 6646
medical research (6605) 6605
antiviral agents (6564) 6564
genotype (6528) 6528
ribavirin (6524) 6524
hepacivirus - genetics (6423) 6423
patients (6279) 6279
analysis (5900) 5900
virus diseases (5796) 5796
viruses (5720) 5720
hepatitis b virus (5675) 5675
ribavirin - therapeutic use (5502) 5502
cirrhosis (5239) 5239
immunology (5112) 5112
animals (5044) 5044
virus-infection (4830) 4830
liver cirrhosis (4773) 4773
hepatitis b, chronic - drug therapy (4699) 4699
prevalence (4678) 4678
adolescent (4656) 4656
hiv (4620) 4620
biological response modifiers (4591) 4591
pharmacology & pharmacy (4587) 4587
recombinant proteins (4570) 4570
hepatitis c - drug therapy (4539) 4539
medicine, experimental (4503) 4503
clinical trials (4435) 4435
medicine (4303) 4303
antiviral agents - administration & dosage (4301) 4301
retrospective studies (4300) 4300
hepatology (4246) 4246
disease (4184) 4184
hepatitis c, chronic - complications (4172) 4172
young adult (4169) 4169
liver cancer (4149) 4149
antiviral agents - adverse effects (4111) 4111
viral load (4037) 4037
human immunodeficiency virus--hiv (4019) 4019
hepatitis c, chronic - virology (3960) 3960
hepatocellular-carcinoma (3956) 3956
mortality (3763) 3763
gastroenterology and hepatology (3683) 3683
hcv (3670) 3670
transplantation (3659) 3659
digestive system diseases (3658) 3658
hepatocellular carcinoma (3598) 3598
medicine, general & internal (3588) 3588
genetic aspects (3574) 3574
studies (3568) 3568
hepacivirus - drug effects (3490) 3490
research article (3485) 3485
oncology (3472) 3472
medicine & public health (3424) 3424
lamivudine (3419) 3419
epidemiology (3411) 3411
fibrosis (3318) 3318
genotype & phenotype (3281) 3281
diagnosis (3182) 3182
pharmaceutical industry (3168) 3168
time factors (3135) 3135
polyethylene glycols - therapeutic use (3131) 3131
chronic hepatitis-c (3121) 3121
hepatitis b virus - genetics (3082) 3082
prognosis (3075) 3075
proteins (2992) 2992
liver - pathology (2983) 2983
liver transplantation (2976) 2976
cancer (2934) 2934
virus (2929) 2929
microbiology (2907) 2907
biopsy (2882) 2882
gastroenterology (2819) 2819
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (76239) 76239
French (578) 578
German (488) 488
Spanish (473) 473
Japanese (365) 365
Chinese (330) 330
Portuguese (300) 300
Russian (209) 209
Polish (149) 149
Italian (108) 108
Korean (105) 105
Hungarian (79) 79
Croatian (36) 36
Turkish (35) 35
Czech (31) 31
Dutch (22) 22
Serbian (21) 21
Danish (18) 18
Norwegian (18) 18
Arabic (14) 14
Romanian (13) 13
Swedish (12) 12
Ukrainian (10) 10
Hebrew (8) 8
Slovak (7) 7
Persian (5) 5
Finnish (3) 3
Urdu (3) 3
Bosnian (2) 2
Bulgarian (2) 2
Slovenian (2) 2
Albanian (1) 1
Hindi (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of internal medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 1 - 13
Journal Article
PloS one, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy... 
VIRUS-INFECTION | CHEMOKINES | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PROTEIN-10 | GENOTYPE 1 INFECTION | PREDICTIVE-VALUE | RIBAVIRIN | INDUCTION | ASSOCIATION | SPONTANEOUS CLEARANCE | Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
Annals of internal medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 434 - 441
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2012, Volume 156, Issue 4, pp. 279 - 290
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0172159
Journal Article